FGFR2/Nrf-2 axis in luminal breast cancer and the effects on cell growth and response to anti-ER drugs

2020/37/N/NZ3/01401

Keywords

Descriptors

  • NZ3_001: Biologia komórki
  • NZ3_007: Przekaźnictwo sygnału
  • NZ5_003: Patogeneza chorób człowieka

Panel

NZ3 – Cellular and developmental biology: cell biology, developmental biology, ageing biology, neurobiology

Host institution

Gdański Uniwersytet Medyczny, Międzyuczelniany Wydział Biotechnologii Uniwersytetu Gdańskiego i Gdańskiego Uniwersytetu Medycznego

Voivodeship: pomorskie

Other projects carried out by the institution »

Principal investigator (from the host institution)

dr Monika Górska-Arcisz

Number of co-investigators in the project: 2

Call

PRELUDIUM 19 – announced on 2020-03-16

Amount awarded
210 000 PLN
Project start date
2021-02-05
Project end date
2025-02-04
Project duration
48 months (the same as in the proposal)
Project status
Project settled

Project description

Download the project description in a pdf file

Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Information in the final report

Publication in academic press/journals (1)

  1. FGFR2-triggered autophagy and activation of Nrf-2 reduce breast cancer cell response to anti-ER drugs

    Authors:
    Monika Gorska-Arcisz, Marta Popeda, Marcin Braun, Dominika Piasecka, Joanna I. Nowak, Kamila Kitowska, Grzegorz Stasilojc, Marcin Okroj, Hanna M. Romanska, Rafal Sadej
    Academic press:
    Cellular & Molecular Biology Letters (year: 2024, volume: 29, pages: numer artykułu: 71), Publisher: Springer Nature
    Status:
    Published
    DOI:
    10.1186/s11658-024-00586-6 – link to the publication

« New search

Graphic design and implementation: Jakub Piotrowski